期刊
CANCER CELL
卷 36, 期 3, 页码 215-217出版社
CELL PRESS
DOI: 10.1016/j.ccell.2019.08.009
关键词
-
资金
- Memorial Sloan Kettering Cancer Center (MSKCC) NCI [P30 CA008748]
- Ludwig Collaborative
- Swim Across America Laboratory
It has been widely assumed that PD-1 blockade works by reinvigorating (rebooting'') pre-existing exhausted tumor-infiltrating ilymphocytes (TILs). A recent study challenges this paradigm, demonstrating that the majority of tumor-specific TILs after anti-PD-1 treatment have TCRs not identified in the tumor pre-therapy, suggesting they are newly recruited post-therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据